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Abstract 
Background: Traditional remedies have been used for many years in Africa to treat various ailments before the 
introduction of conventional medicines into the continent. Concurrent use of traditional herbal medicines (THM) 
with highly active antiretroviral therapy (HAART) is widespread among HIV infected patients. Studies done in 
different parts of the world show conflicting health outcomes among HIV positive patients using HAART and 
herbal medicine concurrently with some reporting better health outcomes while others report increased risk of 
adverse drug reactions. However, the extent of THM use is not known in most settings in Sub-Saharan Africa 
Kenya included. This study aimed to determine the prevalence and factors associated with THM use among HIV 
infected patients on highly active antiretroviral therapy (HAART) attending two comprehensive care centers in 
Nairobi County.  
Methods: A descriptive cross-sectional study was conducted at Kenyatta National Teaching and Referral Hospital 
and Mbagathi District Hospital. From the two centers a total of 370 participants were selected via systematic 
random sampling. The participants included were those aged 18 years and above, on HAART, and had consented 
to participate in the study. Data was collected using an interviewer-administered semi-structured questionnaire 
seeking information on herbal medicine use, socio-demographic and economic factors associated with herbal 
medicine use and the association between herbal medicine use and occurrence of adverse drug reactions. THM use 
referred to someone who had ever used or was currently using herbal medicine while on highly active antiretroviral 
therapy (HAART) by the time of the study. Data was captured in excel sheet and exported to STATA for analysis. 
Results: The study established that the prevalence of herbal medicine use among HIV positive patients taking 
HAART was 15.5%. About 77.8% of the patients who had used herbal medicine had never disclosed to the doctor 
or any health care worker at the CCC about their herbal medicine use. Herbal medicine use led to decreased 
adherence to HAART. The longer the duration between HIV diagnosis and HAART start, the more likely a HIV 
positive patient was to use herbal medicine. Patients who use herbal medicine with HAART were more likely to 
experience adverse drug reactions. There were 59.7% participants who had good /fair adherence while 40.3% had 
poor adherence. Majority of those who had poor adherence had significantly higher proportion of side effects as 
compared  to those had good/fair adherence. 
Conclusion: The prevalence of THM use among participants on HAART was high. This raises clinical and 
pharmacological concerns that need attention by the health care service providers. 
Keywords: Herbal Medicine, HIV, Antiretroviral Therapy 
DOI: 10.7176/JBAH/9-4-11 
 
1. Introduction 
Traditional remedies have been used for many years in Africa to treat various ailments before the introduction of 
conventional medicines into the continent. The term “traditional medicine” refers to ways of protecting and 
restoring health that existed before the arrival of modern medicine. Thus, in all countries of the world there exists 
traditional knowledge related to the health of humans and animals. The importance of traditional medicine (TM) 
as a source of primary healthcare was first officially recognized by the World Health Organization (WHO) in the 
Primary Health Care Declaration of Alma Ata (1978) and has been globally addressed since 1976 by Traditional 
Medicine Program of the WHO. 
The wide spread use of traditional medicine (TM) among both rural and urban population could be attributed to 
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cultural acceptability, physical accessibility and economic affordability, as well as efficacy against certain types of 
diseases, as compared to modern medicine (Mukherjee, 2002). 
In Kenya, patients would opt for traditional herbal medicine because the traditional herbal medicine practitioners 
are more accessible than the trained doctors. A large number of the rural poor, in particular, turn to traditional 
medical practitioners for certain conditions, when access to allopathic health workers is restricted (Lambert et al., 
2011) 
In Africa many HIV patients use traditional herbal medicine for primary health care or management of side effects 
(Babb et al, 2007). Traditional beliefs, inconsistent access or unavailability of antiretroviral drugs has led to 
increase in the use of herbal remedies among HIV-infected individuals in Africa in the past decade (Maponga et 
al., 2007). There is no ultimate cure for HIV and this has led to people trying different things in an attempt to get 
cured. Some of the herbal drugs have been reported to cause adverse effects and there have been reports of drug 
interactions with antiretroviral drugs (Izzo, 2004). These herbal substances could induce enzymes involved in the 
metabolism of antiretroviral drugs resulting in low plasma concentrations of the drugs or alternatively inhibit the 
enzymes resulting to higher plasma concentrations of the drugs which would exacerbate their toxicity (Lee et al., 
2006). 
These life prolonging HAART have several significant side effects and the management of these side effects 
remains a major challenge especially in the developing countries and this has also contributed to the use of 
complementary and alternative medicines (UNAIDS, 2008). Herbal medicines do present various health 
challenges. The multiplicity of these medicines leads not only to potentially severe side effects, but also to 
clinically significant interactions between ARVs and other medicines. In Canada, majority of the patients who 
reported HAART related side effects especially neuropathy, also used complementary or alternative medicine 
(Agnoletto et al., 2006). Use of HAART concurrently with traditional herbal medicine may lead to drug 
interactions undermining the effectiveness of antiretroviral drugs (Lee et al., 2006).  
HIV patients on HAART may not inform medical practitioners about their herbal medicine use as they believe it 
is not important and taking herbal medicine together with prescribed drugs is harmless especially if for different 
problems or fear of being treated differently by the healthcare providers (Vickers et al., 2006).  Even though there 
is a general feeling that herbal medicines are safe, a review of toxicity and quality control issues of herbal 
medicines in Kenya reveal the existence of contamination of herbal medicines with heavy metals, undocumented 
pharmaceuticals, misidentified plants, pesticides, excessive levels of microorganisms or their toxins and other 
noxious organic materials as well as high bacteria content that poses serious health risks (Maina et al., 2013).  
The standard anti-retroviral drugs (ARVs) used for the treatment of HIV/AIDS have significant side effects 
resulting in lack of adherence and the emergence of multidrug resistant viral strains. The side effects experienced 
by HIV patients lead to distrust of conventional therapy and are likely to turn to complementary and alternative 
medicine (Hsiao et al., 2003). Negative attitude towards the effectiveness of HAART and greater desire for medical 
information by HIV infected patients makes them more likely to use complementary and alternative medicines 
which have the potential to cause adverse effects (Lee et al., 2006). 
This study was therefore conducted to determine prevalence and factors associated with herbal medicine use 
among HIV positive patients on highly active antiretroviral therapy in selected hospitals in Nairobi county 
 
2. Methodology  
2.1 Study design 
The research adopted a facility based descriptive cross-sectional study which recruited HIV positive patients on 
HAART aged 18 years and above attending Kenyatta National Teaching and Referral Hospital CCC and Mbagathi 
District Hospital CCC between June – July 2015. A semi-structured questionnaire was administered to patients 
who met the selection criteria. Participants received information on the study including the time required for 
questionnaire completion and assured anonymity of their responses. 
2.2 Study area  
The study was conducted at Kenyatta National Hospital(KNH) and Mbagathi District Hospital both in Nairobi 
County. Mbagathi District Hospital is located approximately 4 kilometers from the city center. It has a bed capacity 
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of 200 and offers a variety of services including Antiretroviral Therapy, Curative In-patient Services, Family 
Planning, HIV Counseling and Testing, Immunization and many others. The facility is easily accessible from the 
city center and is well known as it was the district referral center giving it a wide catchment area. It has a history 
of being an infectious disease hospital   hence it popularity among Nairobi residents. It serves close to 4000 HIV 
positive patients taking HAART making it an ideal center for the study.  
KNH is the largest public health facility and is located in the city about 3 kilometers from the city center. It is 
about 112 years old. It covers an area of 45.7 hectares and within the KNH complex are College of Health Sciences 
(University of Nairobi); the Kenya Medical Training College; Kenya Medical Research Institute (KEMRI)  and 
National Laboratory Service .It  has 50 wards, 22 out-patient clinics, 24 theatres and Accident & Emergency 
Department. It has a total bed capacity of 1800 out of which 209 beds are for the Private Wing. It is accessible to 
the majority of the population in the county due to its strategic geographical location and the health capacity of the 
facility. It is the national referral hospital and all the complicated medical conditions that cannot be managed in 
other hospitals are usually referred to KNH. The facility serves over 5000 HIV positive patients taking HAART.  
2.3 Subject selection  
The study participants from the two sites were selected by Systematic random sampling. We recruited 160 
participants from Mbagathi and 210 from KNH weighted to the number of patients that usually received treatment 
at each facility. The subjects recruited into the study were those that were HIV positive, above 18 years, taking 
HAART from the study sites, able to respond to study questions, willing to participate in the study and were 
Nairobi residents.  
2.4 Data collection 
Primary data was obtained using an interviewer administered semi structured questionnaire. The questionnaire was 
prepared in both English and Swahili languages. The questionnaire was administered to the participants and the 
responses were written down and it approximately took 20 minutes to complete the questionnaire.   
The type of data collected included demographic characteristics of the participants; age, sex, religion, highest level 
of education attained, marital status, drug related factors including adherence to HAART, duration on HAART, 
and side effects; individual factors including familiarity with herbs, beliefs in the usefulness of THM, why they 
started using THM, what herb was taken and how. Medication adherence was assessed using the validated Morisky 
medication adherence scale in outpatient setting (Morisky et al., 2008).  
2.5 Ethical issues 
The study was approved for research by KEMRI Scientific Steering and Ethical Review Committees, KNH ethics 
review committee and the medical superintendent Mbagathi District Hospital. 
2.6 Data management and analysis 
All study participants received a unique participant identification number that was recorded on the questionnaire.  
Collected data from the study was checked for accuracy and completeness.  The data was stored in flash disks, 
compact disks and a laptop for back up before and after analysis.  Data on the questionnaire was kept under lock 
and key while electronically stored data was password protected. The data was keyed in Microsoft Excel and then 
exported to STATA for analysis.  
Dependent variables include prevalence of herbal medicine use and occurrence of ADRs. Chi square test was 
computed for categorical variables to test for association between predictor and outcome.  
All variables observed to be significant were subjected to multivariate regression analysis to test for interaction. 
Level of significance was determined at 5% (p-value < 0.05) 
Software used was SPSS.  
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3. Results 
3.1 Socio-demographic and economic characteristics of patients on HAART 
A total of 370 participants were recruited into the study. There were 136(36.8%) males and 234(63.2%) Females. 
A total of 8(2.2%) participants were below 25 years, 41 (11.3%) were 25-29 years, 52 (14.4%) were 30-34 years, 
48(13.4%) were 35-39 years, 72(19.9%)were 40-44 years, 69(19%) were 45-49 years, 41 (11.3%) were 50-54 
years, and 31(8.6%) participants were aged over 55years. The married participants were 208(61.5%), single 78 
(23%), divorced 18(5.3%) and 34 (10%) participants were separated. A total of 125(33.9%) participants had 
acquired tertiary education, 163(44.2%) had secondary school, 70 (19%) had primary and 11(3%) had no education. 
With regard to employment status 113(32%) participants were in private business, 170(48%) were employed and 
70(19.8%) were unemployed.  There were 7(2.4%) participants who had a monthly household income less than 
Ksh5000, 29(10%) earned between ksh5000-ksh9999, 71(24.48%) earned ksh10000-19999, 70(24.1%) earned 
ksh20000-29999, 28(9.7%) earned ksh30000-39999, 20(6.9%) earned 40000-49999 and 65(22.4%) had a monthly 
income above ksh50000. (Table 1). 
Table 1:  Socio-demographic and economic characteristics of patients on HAART 
 
3.2 Adherence, side effects and HAART start characteristics of patients on HAART  
There were 54(14.8%) participants who were started HAART within 3 years of HIV diagnosis, 71(19.4%) were 
started HAART between 3-5 years, 110(30%) between 6-8 years, and 131(35.8%) were started HAART more than 
9 years after HIV diagnosis. There were 221(59.7%) participants who achieved good /fair adherence while 
149(40.3%) had poor adherence. After starting HAART, 228(62%) participants reported to have experienced side 
effects while 140(38%) didn’t experience any side effects. (Table 2).  
 
Variable Frequency  percentage 
Gender Male  136 36.76 
 Female  234 63.24 
Age Category in Years Below 25  8 2.21 
 25-29 41 11.33 
 30-34 52 14.36 
 35-39 48 13.26 
 40-44 72 19.89 
 45-49 69 19.06 
 50-54 41 11.33 
 55 and above 31 8.56 
Marital Status Single  78 23.08 
 Married  208 61.54 
 Divorced or Separated 52 15.39 
Level of education  No education  11 2.98 
 Primary school  70 18.97 
 Secondary school  163 44.17 
 Tertiary education  125 33.88 
Employment status  Unemployed  70 19.83 
 Employed  170 48.16 
 Private business  113 32.01 
Monthly household income (Ksh) Below 9999 36 12.41 
 10000-19999 71 24.48 
 20000-29999 70 24.14 
 30000-39999 28 9.66 
 40000-49999 20 6.90 
 Above 50000 65 22.41 
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Table 2: Adherence, side effects and HAART start characteristics of patients on HAART 
 
3.3 Prevalence of herbal medicine use among HIV positive patients on HAART  
The Prevalence of herbal medicine use among HIV positive patients on highly active antiretroviral therapy was 
15.5%. (Table 3).  
Table 3: Prevalence of herbal medicine use among HIV positive patients on HAART 
Herbal & HAART  use  Frequency  Percent       
No 305 84.49 
Yes 56   15.51       
3.4 Socio-demographic, economic factors and herbal medicine use among HIV positive patients taking 
HAART. 
The study established that 17% of HIV positive women and 12.9% of HIV positive men taking HAART used 
herbal medicine. It was observed that 12.1% HIV positive patients aged 18-35 years taking HAART used herbal 
medicine while 16.8% of those aged above 35 years used herbal medicine. (Table 4).  
 
3.5 Adherence, side effects, HAART start and herbal medicine use among HIV positive patients taking 
HAART. 
The longer the duration between HIV diagnosis and HAART start, the more likely a HIV positive patient was to 
use herbal medicine (P< 0.05). Patients who were started HAART more than 9 years after HIV diagnosis had 
higher odds of using herbal medicine (OR: 4.6, 95% CI: 1.283-12.045). Patients who had poor adherence are more 
likely to use herbal medicine. (P<0.01).  The use of herbal medicine with HAART increases the risk of side effects 
(P< 0.01). (Table 5) 
 
 
  
Variable Frequency  Percentage  
Duration in years between HIV diagnosis 
and HAART start  
Less than 3 years  54 14.75 
 3-5 71 19.40 
 6-8 110 30.05 
 More than 9 years  131 35.79 
Adherence  Good/  Fair 221 59.73 
 Poor 149 40.27 
Side effects after HAART start  Experienced side effects  228 61.96 
 Didn’t experience side effects  140 38.04 
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Table 4: Bivariate analysis of socio-demographic, socio-economic factors and herbal medicine use among 
HIV positive patients on HAART 
Variable Herbal Use Test Stat, P- value 
No Yes Total 
No. Col% No. Col% No. Col% 
Gender (n=361) Male 115 37.7 17 30.4 132 36.6 Pearson chi2(1)= 
1.1013, Pr= 0.294 
 Female 190 62.3 39 69.6 229 63.4 
Age (n=355) <35 87 29 12 21.8 99 27.9 Pearson chi2(2) = 
1.1921, Pr = 0.551  35-44 99 33 20 36.4 119 33.5 
 45+ 114 38 23 41.8 137 38.6 
Marital Status 
(n=331) 
Not Married  107 38.1 20 40 127 38.4 Pearson chi2(1) = 
0.0663, Pr = 0.797 
 Married  174 61.9 30 60 204 61.6 
Education (n=360) Primary or less 68 22.4 10 17.9 78 21.7 Pearson chi2(2) = 
0.7427, Pr = 0.690  Secondary 136 44.7 25 44.6 161 44.7 
 Tertiary 100 32.9 21 37.5 121 33.6 
Employment 
(n=344) 
Unemployed 
57 19.7 12 22.2 69 20.1 Pearson chi2(2) = 
0.2006, Pr = 0.905 
 
Employed 
142 49 26 48.1 168 48.8 
 Private 
Business 
91 31.4 16 29.6 107 31.1 
Income (n=282) <20000 90 37.3 16 39 106 37.6 Pearson chi2(2) = 
0.8298, Pr = 0.660 
 20000-39999 76 31.5 15 36.6 91 32.3 
 40000 and 
above 
75 31.1 10 24.4 85 30.1 
 
Table 5: Bivariate analysis of adherence, side effects, HAART start factors and herbal medicine use among 
HIV positive patients on HAART 
Variable Herbal Use Test Stat, P- value 
No Yes Total 
No. Col% No. Col% No. Col% 
Duration in years between HIV 
diagnosis and HAART 
(n= 357) 
Less than 
3years 
48 15.9 4 7.3 52 14.6 
Pearson chi2(3) = 9.0929, 
Pr = 0.028 
 
3-5 
58 19.2 12 21.8 70 19.6 
 6-8 97 32.1 11 20 108 30.3 
 More than 9 
years 
99 32.8 28 50.9 127 35.6 
Adherence (n=361) Good / Fair 191 62.7 24 42.9 215 59.5 Pearson chi2(2) = 7.6742,  
Pr = 0.006 
 Poor 114 37.4 32 57.1 146 40.4 
Side effects after HAART start (n=360) 
No 125 41.1 11 19.6 136 37.8 
Pearson chi2(1) = 9.2783, 
Pr = 0.002 
 Yes 179 58.9 45 80.4 224 62.2 
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3.6 Multivariate analysis of factors associated with herbal medicine use among HIV positive patients 
taking HAART 
The factors that were independently associated with herbal medicine use were a more than 9 years’ duration 
between HIV diagnosis and HAART start, poor adherence to HAART and side effects after HAART start.  Patients 
who were started HAART more than 9 years’ after HIV diagnosis were four times more likely to use herbal 
medicine as compared to those who were started HAART within 3 years of HIV diagnosis. Patients who had poor 
adherence to HAART had higher odds of using herbal medicine. Patients who had experienced side effects after 
HAART start were three times more likely to have used herbal medicine. (Table 6).  
 
Table 6: Multivariate model for factors associated with herbal medicine use among HIV positive patients 
taking HAART 
Variable  OR (95% CI) P-value 
Duration in years between HIV 
diagnosis and HAART start  
Less than 3 years Ref 
  3-5 years 2.692 (0.761-9.561) 0.087 
  6-8 years 1.673 (0.445 -5.608) 0.392 
  More than 9 years 4.631(1.283-12.045) 0.009 
Adherence  Good/ Fair Ref 
  Poor 2.84 (1.55 - 7.81) 0.027 
Side effects after 
HAART start  
Didn’t experience side 
effects 
Ref 
  Experienced side effects 3.402 (2.015-4.165) 0.031 
 
3.7 Socio-demographic, economic factors and occurrence of adverse drug reaction among HIV positive 
patients taking HAART. 
The study established that 62% of HIV positive patient experienced adverse drug reactions after HAART start. A 
higher proportion of males had side effects as compared to females, 84 (62.7%) vs. 144 (61.5%), without statistical 
significance, p= 0.827. There was no significant difference in proportion with side effects by marital status, p = 
0.845. Similarly, there was no difference in proportion with side effects by education level and income level, p 
=0.205 and p=0.204 respectively. There was a higher proportion of those employed with side effects, 114 (52.5%) 
vs. 56 (41.8%), p= 0.147, without any statistical significance. (Table 7). 
 
 
 
 
 
 
  
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) DOI: 10.7176/JBAH 
Vol.9, No.4, 2019 
 
95 
Table 7: Bivariate analysis of socio-demographic, socio-economic factors and occurrence of adverse drug 
reactions among HIV positive patients on HAART 
 
Side Effects No (n=140) Yes (n=228) Total (n=368) Test statistic, P value 
 
  No. Col % No. Col % No. Col %   
Gender (n=368) 
 Male 50 35.7 84 36.8 134 36.4 
Pearson chi2(1) = 
0.0477, Pr = 0.827 
 Female  90 64.3 144 63.2 234 63.6  
Age (n=360) 
<35  32 23.2 69 31.1 101 28.1 
Pearson chi2(2) = 
2.8606, Pr = 0.239 
 35-44  51 37 69 31.1 120 33.3  
 
45+  55 39.9 84 37.8 139 38.6  
Marital status 
(n=337) Not Married  51 39.2 79 38.2 130 35.6 
Pearson chi2(2) = 
0.0383 Pr = 0.845 
 Married  79 60.8 128 61.8 207 61.4  
Education Level 
(n=366) Primary or less  37 26.6 44 19.4 81 22.1 
Pearson chi2(2) = 
3.1731, Pr = 0.205 
 
 Secondary  61 43.9 101 44.5 162 44.3  
 
Tertiary  41 29.5 82 36.1 123 33.6  
Employment 
Status (n=351) Unemployed  30 22.4 40 18.4 70 19.9 
Pearson chi2(2) = 
3.8313, Pr = 0.147 
 Employed  56 41.8 114 52.5 170 48.4  
 Private business  48 35.8 63 29 111 31.6  
Income level 
(n=288) <20000  39 36.1 67 37.2 106 36.8 
Pearson chi2(2) = 
3.1766, Pr = 0.204 
 20000-39999  31 28.7 66 36.7 97 33.7  
 40000 and 
above 38 35.2 47 26.1 85 29.5  
 
3.8 Bivariate analysis of adherence, HAART start factors and occurrence of adverse drug reactions 
among HIV positive patients on HAART 
There was a significant difference in proportion of those with side effects by duration in years between HIV 
diagnosis and HAART start, p <0.01. Majority of those who had poor adherence had significantly higher proportion 
of side effects as compared  those had good/fair adherence , 104 (45.65) vs. 45 (32.1%), p =0.011. (Table 8). 
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Table 8: Bivariate analysis of adherence, HAART start factors and occurrence of adverse drug reactions 
among HIV positive patients on HAART 
 
Side Effects No (n=140) Yes (n=228) Total (n=368) Test statistic, P value 
 
  No. Col % No. Col % No. Col %   
Duration in years 
between 
HIV diagnosis 
and HAART 
(n=364) <3 (n=54) 11 8 43 18.9 54 14.8 
Pearson chi2(3) = 
12.2605, Pr = 0.007 
 
3-5 (n=69) 21 15.3 48 21.1 69 19  
 6-8 (n=110) 46 33.6 64 28.2 110 30.2  
 
>9 (n=131) 59 43.1 72 31.7 131 36  
Adherence 
(n=368) 
Good/Fair 
(n=219) 95 67.9 124 54.4 219 59.5 
Pearson chi2(1) = 
6.5327, Pr = 0.011 
 
Poor (n=149) 45 32.1 104 45.6 149 40.5  
 
3.9 Logistic regression of socio-demographic, economic factors, HAART start and occurrence of 
adverse drug reaction among HIV positive patients taking HAART. 
On univariable analysis, females had a slightly lowered odds of having a side effect OR= 0.95 95% CI (0.62-1.48), 
p= 0.827 without statistical significance.  
Those started HAART 6-8 years after HIV diagnosis, OR= 0.36  95% CI (0.17-0.76), and those started more than 
9 years OR= 0.31  95% CI (0.15-0.66) had statistically significant lower odds of side effects compared to those 
started HAART less than 3 years after diagnosis, p=0.008 and p=0.002 respectively. Those with poor adherence 
compared to those with good or fair adherence, had statistically significant higher odds of side effects, OR= 1.77 
95% CI (1.14-2.75). 
Multivariable model included all the variables. On multivariable analysis, patients started HAART 6-8 years after 
HIV diagnosis, OR= 0.35 95% CI (0.13-0.91), and more than 9 years OR= 0.27  95% CI (0.1-0.73) had statistically 
significant lower odds of side effects compared to those started HAART less than 3 years, p=0.032 and p=0.009 
respectively. Patients with poor adherence compared to those with good or fair adherence, had statistically 
significant higher odds of side effects, OR= 2.38 95% CI (1.33-4.27), p=0.004. (Table 9). 
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Table 9: Multivariate model for factors associated with adverse drug reactions among patients on HAART 
 
Side Effects (Yes vs. No) Univariable OR P value Multivariable OR P value 
Gender 
 Male  Ref  Ref  
 Female  0.95 (0.62-1.48) 0.827 1.28 (0.72-2.3) 0.403 
Age Category <35  Ref  Ref  
 
35-44  0.63 (0.36-1.09) 0.099 1.06 (0.49-2.31) 0.883 
 45+  0.71 (0.41-1.22) 0.210 1.19 (0.54-2.6) 0.668 
Marital status Not Married  Ref  Ref  
 
Married  1.05 (0.67-1.64) 0.845 1.17 (0.54-2.17) 0.639 
Education 
Level 
Primary school or less  Ref  Ref  
 Secondary school  1.39 (0.81-2.39) 0.230 1.38 (0.62-3.05) 0.428 
 
Tertiary  1.68 (0.95-2.99) 0.077 2.43 (0.94-6.25) 0.0663 
Employment 
Status 
Unemployed  Ref  Ref  
Employed  1.53 (0.86-2.7) 0.147 2.26 (0.24-21.6) 0.480 
 
Private business  0.98 (0.54-1.8) 0.959 1.73 (0.18-16.7) 0.635 
Income level <20000  Ref  Ref  
 
20000-39999  1.24 (0.69-2.22) 0.469 1.32 (0.63-2.75) 0.463 
 
40000 and above  0.72 (0.4-1.29) 0.268 0.57 (0.26-1.26) 0.164 
Duration in 
years between 
<3  Ref  Ref  
3-5 0.59 (0.25-1.35) 0.209 0.63 (0.22-1.83) 0.399 
6-8 0.36 (0.17-0.76) 0.008 0.35 (0.13-0.91) 0.032 
 >9  0.31 (0.15-0.66) 0.002 0.27 (0.1-0.73) 0.009 
Adherence 
Good/Fair  Ref  Ref  
 
Poor  1.77 (1.14-2.75) 0.011 2.38 (1.33-4.27) 0.004 
 
3.10 Benefits of HAART known by HIV positive patients on HAART 
The benefits of taking HAART were known by 359(98.4%) participants with 6(1.6%) not knowing any benefit of 
taking HAART.  The benefits known to study participants were to suppress viral load, improve or prolong life and 
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Figure 1: Benefits of taking HAART known by HIV positive patients taking HAART 
3.11 Side effects experienced by HIV positive patients on HAART 
After HAART start, 62% of the patients experienced side effects. The side effects experienced were nausea and 
vomiting 47(20.6%), drowsiness 42(18.4%), dizziness 31(13.6%), hallucinations and joint pains 39(17.1%), skin 
rashes 13(5.7%), weight loss 17(7.5%) and night mares 15(6.6%) and other side effects 24(10.5%). (Figure 2)   
 
Figure 2: Side effects experienced participants After HAART start 
3.12 Types of herbal medicine used by HIV positive patients on HAART 
The types of herbal medicine used by HIV positive patients on HAART included Loliondo 20(35.7%), aloevera 
12(21.4%), marijuana 9(16%) while 15(26.8%) users did not know the names of herbal medicines they used. 
(Figure 3) 
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Figure 3:  Types of herbal medicines used by HIV positive patients on HAART 
 
3.13 Routes of administration of herbal products used by HIV positive patients on HAART  
The routes of administration of herbal products by HIV positive patients on HAART were oral 100%, topical 7%, 
inhalation at 7%, rectal 2% and vaginal 0%. (Figure 4).  
Figure 4: Routes of administration of herbal products used by HIV positive patients on HAART 
 
3.14 Sources of education programs on herbal medicine for HIV treatment  
The sources of education programs on herbal medicine for HIV treatment were TV (79%), radio (72.4%), 
newspaper (35.7%), magazine (25.5%), books (23.8%), internet (38%), market place (87.8%), religious gathering 
(20.3%). (Figure 5).  
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Figure 5: Sources of education programs on herbal medicine for HIV treatment  
 
3.15 Money spent per month on herbal medicine by HIV positive patients on HAART 
The study established that approximately 45% of the participants who use herbal medicine spent less than 
Ksh1,000/= per month on herbal medicines while about 15% spent over Ksh5,000 per month on herbal medicine. 
(Figure 6).  
Figure 6: Money spent per month on herbal medicine  
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3.16 Reasons for preferring herbal medicine, sources and disclosure of herbal medicine use by HIV 
positive patients on HAART 
The reasons for preferring herbal medicine is that it is easily accessible (97.79%), more acceptable (97.26%) and 
also because herbal medicine is cheap (92.86%). The sources of herbal medicine were the herbalist (92.59%), 
garden (87.06%), friends (80.77%), pharmacy (50.00%). With regard to disclosure of herbal medicine use to health 
care workers, 67.3% of the participants who used herbal medicine had never disclosed their herbal medicine use 
to any clinician at the comprehensive care Centre. After herbal medicine use, 44.2% of HIV positive patients on 
HAART felt that their health improved. The study established that 16.1% of HIV positive patients on HAART 
who used herbal medicine had ever stopped taking HAART to take herbal medicine.  
4.0 Discussion  
4.1 Prevalence of herbal medicine use among HIV positive patients on HAART  
The study established that 15.51% of the study participants used herbal medicine together with HAART. These 
finding concur to those of Babb et al (2007) that in Africa many HIV patients use traditional herbal medicine for 
primary health care or management of side effects. The prevalence of herbal medicine use among HIV positive 
patients on antiretroviral therapy in this study was lower than in Uganda (33.7%) as reported by Namuddu et al 
(2011). This could be attributed to patient education by health care providers that discourage the patients from 
taking herbal remedies while on HAART. A study by Bepe et al (2011) established that 54% of the patients were 
taking antiretroviral drugs together with one or more traditional herbal remedies. In this study more 17% of females 
and 12.9% of males reported to be using herbal medicines with HAART. The study findings are consistent with 
the findings of Agnoletto et al (2006) that showed CAM use was more common among females than males with 
an odds ratio of 1.6; 95% confidence interval.  
4.2 Socio-demographic, economic factors and herbal medicine use among HIV positive patients 
taking HAART. 
In this study, the prevalence of herbal medicine use among the women (17%) was higher than that in men (12.9%), 
but this was not statistically significant.  A study by Gore-Felton et al (2003) established that women were four 
times more likely to use alternative therapies than men. Furler et al (2003) observed that Complementary and 
alternative medicine use in Canadian patients with HIV was extremely common, with higher use among women.  
The study established that the prevalence of herbal medicine use among HIV positive patients on HAART who 
had attained tertiary education (17.4%) was higher than for those who had attained secondary school education 
(15.5%) and those who had primary school education (12.8%), but this was not statistically significant. These 
results compare well with what was reported by Bica et al (2003) that users of ingested complementary therapies 
were more likely to be at least high school educated.  
In this study, there was no statistically significant association between employment status and herbal medicine use. 
This is unlike what was observed by Otang et al (2011) who reported that the proportion of unemployed HIV/AIDS 
patients who used herbs for symptom management was significantly higher than that of the employed.  
4.3 Adherence and herbal medicine use among HIV positive patients taking HAART. 
The study established that herbal medicine use led to decreased adherence to HAART (P-value 0.006). These 
findings are consistent with the findings of Peltzer et al (2010) that the use of herbal treatments was associated 
with ARV non-adherence. The findings of this study are consistent with those of Namuddu et al (2011) who 
observed that Participants with HAART adherence levels > 95% were less likely to use traditional herbal medicine.  
4.4 The association between herbal medicine use and occurrence of adverse drug reactions among 
HIV positive patients taking HAART. 
This study established that patients who used herbal medicine with HAART were more likely to experience 
adverse drug reactions, p-value < 0.01. Bepe et al (2011) observed that abdominal pain (odds ratio = 3.0, p-value 
< 0.01) and rash (odds ratio = 2.5, p-value < 0.02) are the adverse events significantly associated with herbal drug 
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use during antiretroviral therapy. The findings of this study are unlike what was observed by Mudzviti et al (2012) 
who reported that Patients who used the indigenous herbs Musakavakadzi and Peltoforum africanum were less 
likely to develop adverse drug reactions compared to patients who did not use the herbs.  
4.5 Factors associated with occurrence of adverse drug reactions among HIV positive patients on 
HAART.  
This study established that patients with poor adherence had statistically significant higher odds of side effects 
compared to those with good or fair adherence, ,OR= 2.38 95% CI (1.33-4.27), p=0.004. these findings compare 
well with those of Rajesh et al (2012) who observed  the occurrence of ADRs to antiretroviral therapy was 
significantly associated and significantly predicted with the percentage of adherence being less than 80% (P < 
0.001).  
4.6 Side effects experienced by HIV positive patients on HAART 
In this study 62% of the patients experienced side effects since they started using ARVs. These findings compare 
well with the findings of Tadesse et al (2014) that 89.8% of the study participants experienced at least one adverse 
drug reaction. A study by Masenyetse et al (2015) established that 37% of the patients on Highly active 
antiretroviral drugs experienced adverse drug reactions. The findings of this study correspond with those of 
Mudzviti et al (2012) who observed that 70.4% of the patients experienced at least one ADR during ART treatment.  
4.7 Types of herbal medicine used by HIV positive patients on HAART 
The types of herbal medicine used by HIV positive patients on HAART included Loliondo 20(35.7%), aloe Vera 
12(21.4%), marijuana 9(16%) while 15(26.8%) users did not know the names of herbal medicines they used. The 
choice of herbal medicine could be attributed to availability, geographical accessibility and traditional believes. A 
study by Hasan et al., (2010) reported that among the types of Complementary and alternative medicine used by 
Malaysian patients with HIV/AIDS, 33.8% of the patients used herbal products. Traditional Chinese medicine and 
traditional Malay medicine were the most frequently used types of herbal medicine. The study findings are 
consistent with those of Klassen et al (2007) who reported that some patients didn’t know the specific names of 
the traditional herbal medicines they used.   
4.8 Sources of education programs on herbal medicine for HIV treatment  
The study established that the sources of education programs on herbal medicine for HIV treatment were TV (79%), 
radio (72.4%), newspaper (35.7%), magazine (25.5%), books (23.8%), internet (38%), market place (87.8%), 
religious gathering (20.3%). These findings are consistent with those of Hasan et al., (2010) where most of the 
patients reported using complementary and alternative medicine upon the influence of family members and some 
of them were also seeking information from the mass media after being infected with HIV/AIDS. 
4.9 Reasons for preferring herbal medicine, sources and disclosure of herbal medicine use by HIV 
positive patients on HAART 
The study established reasons for preferring herbal medicine is that it is easily accessible (97.79%), more 
acceptable (97.26%) and also because herbal medicine is cheap (92.86%). These findings are consistent with the 
findings of Lambert et al (2011) that in Kenya, patients would opt for traditional herbal medicine because the 
traditional herbal medicine practitioners are more accessible than the trained doctors but also a large number of 
the rural poor, in particular, turn to traditional medical practitioners for certain conditions, when access to 
allopathic health workers is restricted. Klassen et al (2007) observed that the reasons for use of traditional herbal 
medicine were availability/abundance of THM, treatment effectiveness of THM, proximity of the herbs to the 
patient, familiarity with THM and affordability.  
The study established that the largest source of herbal medicine for the patients was from herbalist (84.2%) and 
the smallest source was from the pharmacy (66.7%). These findings are in line with the findings of Namuddu et 
al (2011) that reported most of the herbs were obtained from registered herbalist and very few were obtained from 
pharmacies.  
This study established that 44.2% of the patients who used herbal medicine felt that their health improved. These 
findings are consistent with the finding of Hasan et al (2010) that in Malysia 40% of HIV positive CAM users felt 
that CAM improved their health status and none of them felt that their health had deteriorated due to CAM use. 
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The study findings are consistent with those of Otang et al (2011) who reported that 32.5% patients disclosed that 
herbal medicine had a significant and great contribution towards the management of their signs/symptoms of 
opportunistic fungal infections.  
The study established that 16.1% of HIV positive patients on HAART who used herbal medicine had ever stopped 
taking HAART to take herbal medicine. This is more than what was reported by Fairfield et al (1998) where the 
study established that 1.7% of the patients decided to take CAM only and not HAART for management of HIV 
infection.  
This study established that 67.3% of the patients who used herbal medicine had never disclosed to the doctor or 
any health care worker at the CCC about their herbal medicine use. These findings are consistent with those of 
Peltzer et al (2008) who reported that HIV infected people don’t like disclosing to the health care professionals 
about their CAM use. A study by Hasan et al (2010) reported that Despite the side-effects experienced by the study 
participants, about 68% and 84% of them did not disclose their complementary and alternative medicine use to 
doctors and pharmacists, respectively. Underlying reasons for nondisclosure were unnecessary to disclose, and 
that health care professionals never asked regarding complementary and alternative medicine use.  
5.0 Conclusions   
 The Prevalence of herbal medicine use among HIV positive patients on highly active antiretroviral 
therapy is 15.5%.  
 Herbal medicine use reduces adherence to HAART whereas 16.1% of HIV positive patients on HAART 
who also use herbal medicine actually stop taking HAART to take herbal medicine.  
 Majority of HIV positive patients who use both HAART and herbal medicines (67.3%) do not disclose 
their herbal medicine use to the health care workers at the CCC clinic.  
 The biggest source of herbal drugs is from the herbalists with the smallest source being from the 
pharmacy.  
 The main reasons why patients opt for herbal medicine is because herbal medicine is easily accessible, 
more acceptable and cheap.  
 Media plays an important role by virtue of information that goes to patients about herbal medicine.  
 The use of herbal drugs increases the chances of the patients experiencing adverse drug reactions once 
started on HAART.  
 
6.0 Recommendations  
1. The prevalence of herbal medicine use among HIV positive patients on HAART is high and therefore 
further investigations ought to be done to establish the safety, efficacy and drug interactions between 
herbal drugs commonly used by HIV positive patients and antiretroviral agents used for HIV/AIDS 
treatment  
2. Herbal medicine use reduces adherence to HAART and therefore adherence being the greatest patient-
enabled predictor of treatment success should be reinforced at every clinic visit.  
3. Majority of HIV positive patients who use both HAART and herbal medicines do not disclose their herbal 
medicine use to the health care workers at the CCC clinic and therefore the healthcare workers should 
routinely discuss with the patients on herbal medicine use at every clinic visit.  
4. The biggest source of herbal drugs is from the herbalists and therefore the government should introduce 
a basic training program for herbalists and also put in place laws and regulations on the use and trade in 
herbal products to enhance patient safety.  
5. There is need for the health sector to reduce barriers to universal access to conventional health care by 
ensuring easier accessibility, affordability and acceptability in the population.  
6. Media plays an important role by virtue of information that goes to patients and therefore there is need 
for regulation of the media content about herbal medicine to protect patients from misleading information.  
7. Concomitant use of herbal drugs with HAART has the potential for drug interactions and ADRs and 
therefore should be discussed routinely in HAART medication use counselling and patients screened 
thoroughly for ADRs for early identification and management.  
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